Posted inStock
Moderna reports surprise profit on higher-than-expected COVID vaccine sales
By Patrick Wingrove (Reuters) – Moderna (NASDAQ:MRNA) reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its COVID-19 vaccine, even with low revenue from…